Towa Pharmaceutical Co., Ltd.

$24.97

$0.91(-3.52%)

Towa Pharmaceutical Co., Ltd.

4553.T

$24.97

$0.91(-3.52%)

Towa Pharmaceutical Co., Ltd.

4553.T

JPX

$24.97

$0.91(-3.52%)

Chart

Upcoming Earnings

Next report date

May 14, 2026

Report period

Q2 2026

EPS Estimate

$1.01

Revenue Estimate

$443.42M

Key stats

52-Week Range$24.97

$14.38

$27.81

Market capitalization

$1.25B

Dividend yield (indicated)

1.88%

Price to earnings Ratio (TTM)

9.78

Basic EPS (TTM)

$2.03

Net income (TTM)

$100.14M

Revenue (TTM)

$1.64B

Avg. volume

120.71K

Beta (1Y)

-0.30

Employees

4.59K

Market capitalization

$1.25B

Dividend yield (indicated)

1.88%

Price to earnings Ratio (TTM)

9.78

Basic EPS (TTM)

$2.03

Net income (TTM)

$100.14M

Revenue (TTM)

$1.64B

Avg. volume

120.71K

Beta (1Y)

-0.30

Employees

4.59K

Screener Quick Check

About Towa Pharmaceutical Co., Ltd.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Itsuro Yoshida

Website

www.towayakuhin.co.jp

Headquarters

2-11, Shinbashi-cho, Osaka, 571-8580

IPO Date

2004-04-05

Identifiers

ISINJP3623150004

Description

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active...

Related Stocks

Mani, Inc.

7730.T

$1,508.00Mkt Cap: $148.54B

Healthcare

Medical - Instruments & Supplies

ISIN:JP3869920003

Nippon Shinyaku Co., Ltd.

4516.T

$32.76Mkt Cap: $2.21B

Healthcare

Drug Manufacturers - Specialty & Generic

ISIN:JP3717600005

Dividend Overview

Dividend yield (indicated)

1.88%

Dividend per share

$0.50annual

Payout ratio (Earnings)

18.2%

Payout ratio (FCF)

62.1%

Dividend growth streak

Dividend CAGR (3Y)

-12.6%

Dividend CAGR (5Y)

+9.9%

Dividend CAGR (10Y)

-8.3%

Dividend yield (indicated)

1.88%

Dividend per share

$0.50annual

Payout ratio (Earnings)

18.2%

Payout ratio (FCF)

62.1%

Dividend growth streak

Dividend CAGR (3Y)

-12.6%

Dividend CAGR (5Y)

+9.9%

Dividend CAGR (10Y)

-8.3%

Financials

Performance

Margin trends

Debt level and coverage

Earnings

Next: Q2 '26

Actual

Estimate

Earnings

Next: Q2 '26

Actual

Estimate

Performance

Margin trends

Debt level and coverage

Earnings

Next: Q2 '26

Actual

Estimate

Earnings

Next: Q2 '26

Actual

Estimate